v3.25.0.1
INVESTMENTS
12 Months Ended
Dec. 31, 2024
INVESTMENTS  
INVESTMENTS

NOTE 6—INVESTMENTS

Investments in non-consolidated affiliates and certain other investments accounted for under the equity method generally include all entities in which the Company or its subsidiaries have significant influence, but not more than 50% voting control, and are recorded in the consolidated balance sheets in other long-term assets. On December 30, 2022, the Company entered into an agreement to sell its 10.0% investment in Saudi Cinema Company LLC for SAR 112.5 million ($30.0 million), and on January 24, 2023, the Saudi Ministry of Commerce recorded the sale of equity and the Company received the proceeds on January 25, 2023. The Company recorded a gain on the sale of $15.5 million in investment income during the year ended December 31, 2023. Investments in non-consolidated affiliates as of December 31, 2024, include interests in DCDC of 14.6%, AC JV, owner of Fathom Events, of 32.0%, SV Holdco, owner of Screenvision, of 18.4%, Digital Cinema Media Limited (“DCM”) of 50.0%, Handelsbolaget Svenska Bio Lidingo of 50.0%, Bergen Kino AS of 49.0%, Odeon Kino Stavanger/Sandnes AS of 49.0%, CAPA Kinoreklame AS (“Capa”) of 50.0% and Vasteras Biografer, Aktiebolaget Svensk Filmindustri & Co (“Vasteras”) of 50.0%. Through its various investments the Company has interests in four U.S. motion picture theatres and 61 theatres in Europe. Indebtedness held by equity method investees is non-recourse to the Company.

Investment in Hycroft

On March 14, 2022, the Company purchased 2.3 million units of Hycroft, with each unit consisting of one common share of Hycroft and one common share purchase warrant. Each warrant is exercisable for one common share of Hycroft at a price of $10.68 per share over a 5-year term through March 2027. The preceding amounts have been adjusted for the one-for-ten reverse stock split Hycroft effectuated on November 15, 2023.

The Company accounts for the common shares of Hycroft under the equity method and we have elected the fair value option in accordance with ASC 825-10. The Company account for the warrants as derivatives in accordance with ASC 815. Accordingly, the fair value of the investments in Hycroft are remeasured at each subsequent reporting period and unrealized gains and losses are reported in investment expense (income). During the years ended December 31, 2024, December 31, 2023, and December 31, 2022, the Company recorded unrealized losses related to the investment in Hycroft of $3.0 million $12.6 million and $6.3 million, respectively, in investment expense (income), respectively.

NCM Transactions

In March 2022, the NCM CUA resulted in a positive adjustment of 5,954,646 common units for the Company. The Company received the units and recorded the common units as an addition to deferred revenues for the ESA at a fair value of $15.0 million. During the year ended December 31, 2022, the Company sold its shares of NCM for $1.5 million and recorded a realized loss in investment expense of $13.5 million. See Note 1The Company and Significant Accounting Policies and Note 2Revenue Recognition for further information regarding CUA and ESA.

DCIP Transactions

During the year ended December 31, 2022, DCIP ceased operations and the Company received a liquidation distribution of $3.4 million which the Company recorded as equity in earnings.

Summary Financial Information

Investments in non-consolidated affiliates accounted for under the equity method as of December 31, 2024, include interests in Hycroft, SV Holdco, DCM, AC JV, DCDC, 61 theatres in Europe, four U.S. motion picture theatres, and other immaterial investments.

Condensed financial information of the Company’s non-consolidated equity method investments is shown below with amounts presented under U.S. GAAP:

(In millions)

    

December 31, 2024

December 31, 2023

Current assets

$

230.8

$

263.8

Noncurrent assets

199.0

 

224.7

Total assets

429.8

 

488.5

Current liabilities

280.4

 

130.9

Noncurrent liabilities

231.5

 

385.0

Total liabilities

511.9

 

515.9

Stockholders’ deficit

(82.1)

 

(27.4)

Liabilities and stockholders’ deficit

429.8

 

488.5

The Company’s recorded investment

53.6

56.4

Condensed financial information of the Company’s non-consolidated equity method investments is shown below and amounts are presented under U.S. GAAP for the periods of ownership by the Company:

Year Ended

December 31,

December 31,

December 31,

(In millions)

    

2024

    

2023

2022

Revenues

$

473.5

$

425.6

$

412.8

Operating costs and expenses

489.9

449.9

498.2

Net loss

$

(16.4)

$

(24.3)

$

(85.4)

Related Party Transactions

The Company recorded the following related party transactions with equity method investees:

As of

    

As of

(In millions)

December 31, 2024

    

December 31, 2023

Due from DCM for on-screen advertising revenue

$

3.9

$

3.3

Loan receivable from DCM

0.6

0.6

Due to AC JV for Fathom Events programming

(1.5)

(2.3)

Loan receivable from Vasteras

0.8

1.0

Due from Capa for on-screen advertising revenue

1.4

1.4

Due to Vasteras

(0.6)

(0.9)

Due to U.S. theatre partnerships

(0.7)

(0.6)

Year Ended

(In millions)

Consolidated Statements of Operations

December 31, 2024

December 31, 2023

December 31, 2022

DCM screen advertising revenues

Other revenues

$

17.8

$

18.8

$

17.0

DCDC content delivery services

Operating expense

1.3

1.4

1.0

Gross exhibition cost on AC JV Fathom Events programming

Film exhibition costs

29.6

17.5

11.6

Screenvision screen advertising revenues

Other revenues

7.3

8.7

6.9

Capa advertising revenues

Other revenues

1.6

1.1

2.4